JV approved: Hutchison Whampoa Sinopharm Pharmaceuticals emerges
HONG KONG – Hutchison China Meditech Ltd. (LSE:HCM) and Sinopharm Group Co. Ltd. (SEHK:1099) have gained regulatory approval for their new joint venture that will provide sales, distribution and marketing services to pharmaceutical companies in China.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter